Amgen builds case for severe asthma drug tezepelumab

[cafead]

via Amgen and partner AstraZeneca have said their recently filed severe asthma drug tezepelumab has shown impressive results in patients who also have nasal polyps, a common complication of the respiratory disease.

article source